Parhelia Biosciences and Sirona Dx announced a partnership to accelerate implementation of spatial biology workflows from discovery through clinical development. The collaboration is designed to address barriers labs face when deploying workflows that can be costly and highly manual. Parhelia will contribute its Spatial Station automation and standardization platform, while Sirona Dx will help integrate and tailor workflows into client research environments. The companies highlighted applications including multiplex immunofluorescence and RNA in situ hybridization. Both cyclic immunofluorescence and imaging mass cytometry were cited as supported modalities, with the stated priority to enable high-quality, reproducible data at scale. Separately, Arcoris Bio also moved to expand commercial reach for immunofluorescence assay kits through a European and North American distribution deal.